Frontlight ResearchEarly access
Trial site
Milan
- 5running trials
- 4closed trials
The trials here
What the 9 trials at this site are about, from their registry records.
- Conditions
- Multiple sclerosis3 trials
- ALS (motor neurone disease)1 trial
- Atopic dermatitis (eczema)1 trial
- Chronic spontaneous urticaria1 trial
- CIDP (chronic inflammatory demyelinating polyneuropathy)1 trial
- Graves' disease1 trial
- Haemophilia1 trial
- Phase
- Phase 35 trials
- Phase 23 trials
- Status
- Active, not recruiting3 trials
- Completed3 trials
- Enrolling by invitation1 trial
- Recruiting1 trial
- Terminated1 trial
- Lead sponsor
- Sanofi8 trials
- Bioverativ, a Sanofi company1 trial
Running trials
Recruiting
Enrolling by invitation
Long-term Safety and Efficacy Study of Riliprubart in Participants With CIDP
Active, not recruiting
Active, not recruiting
Active, not recruiting
Observational Evaluation of Atopic Dermatitis in Pediatric Patients
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- CIDP (chronic inflammatory demyelinating polyneuropathy)1 recruiting
- Graves' disease1 recruiting
Closed trials
Terminated
Phase 2 Study for SAR443820 in Participants With Amyotrophic Lateral Sclerosis (ALS)
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 15 Nov 2026